Home

For decades, scientists have been defeated in their attempts to find a treatment that effectively reverses the life-threatening damage caused by heart attacks.

Now scientists at Novo Biosciences have identified the first and only drug candidate shown to stimulate a damaged heart to repair itself.

Our scientists use a unique, rapid and cost-effective strategy to develop breakthrough drugs to regenerate damaged organs and tissues. These drugs spur the body to heal itself by triggering powerful mechanisms of self-repair and regrowth that lie dormant in our genes. It’s a bold, new approach with the potential to transform the way we treat human disease.

It takes unconventional thinking to change the future.
Novo Biosciences is leading the way.

Media & Press

A Drug Shows an Astonishing Ability to Regenerate Damaged Hearts and Other Body Parts

A Drug Shows an Astonishing Ability to Regenerate Damaged Hearts and Other Body Parts

A once abandoned drug compound shows an ability to rebuild organs damaged by illness and injury.

Read more
Novo Biosciences achieves major milestones in moving trodusquemine into clinical trials

Novo Biosciences achieves major milestones in moving trodusquemine into clinical trials

Novo Biosciences Inc., has achieved several major milestones in its mission of bringing its breakthrough drug candidate, trodusquemine (aka MSI-1436), to market as a...

Read more
Novo Biosciences Receives Federal Grant to Advance Potential Heart Drug

Novo Biosciences Receives Federal Grant to Advance Potential Heart Drug

Novo Biosciences Inc. has announced that it has received a two-year, $1.5 million Small Business Innovation Research (SBIR) grant from the National Institutes of...

Read more
Looking beyond stem cells and tissue engineering: What if lost and damaged tissues and organs could be regenerated simply by taking a drug?

Looking beyond stem cells and tissue engineering: What if lost and damaged tissues and organs could be regenerated simply by taking a drug?

While stem cell and tissue engineering approaches may ultimately deliver on their clinical promise, small molecules that control innate regeneration mechanisms offer...

Read more

Watch our video